Literature DB >> 9012613

Hypothesis testing and effect size estimation in clinical trials.

M Borenstein1.   

Abstract

LEARNING
OBJECTIVES: This paper provides the reader with an overview of several key elements in study planning and analysis. In particular, it highlights the differences between significance tests (statistical significance) and effect size estimation (clinical significance). DATA SOURCES: This paper focuses on methodologic issues, and provides an overview of trends in research. PAPER SELECTION: References were selected to provide a cross-section of the approaches currently being used. The paper also discusses a number of logical fallacies that have been cited as examples in earlier papers on research design.
CONCLUSIONS: Significance tests are intended solely to address the viability of the null hypothesis that a treatment has no effect, and not to estimate the magnitude of the treatment effect. Researchers are advised to move away from significance tests and to present instead an estimate of effect size bounded by confidence intervals. This approach incorporates all the information normally included in a test of significance but in a format that highlights the element of interest (clinical significance rather than statistical significance). This approach should also have an impact on study planning--a study should have enough power to reject the null hypothesis and also to yield a precise estimate of the treatment effect.

Mesh:

Year:  1997        PMID: 9012613     DOI: 10.1016/S1081-1206(10)63363-7

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  6 in total

Review 1.  DSM categories and dimensions in clinical and research contexts.

Authors:  Helena Chmura Kraemer
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

Review 2.  Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalence.

Authors:  Laszlo Tothfalusi; Laszlo Endrenyi; Alfredo Garcia Arieta
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

3.  A pilot test of a peer navigator intervention for improving the health of individuals with serious mental illness.

Authors:  Erin Kelly; Anthony Fulginiti; Rohini Pahwa; Louise Tallen; Lei Duan; John S Brekke
Journal:  Community Ment Health J       Date:  2013-06-07

4.  Study design and baseline results of an open-label cluster randomized community-intervention trial to assess the effectiveness of a modified mass deworming program in reducing hookworm infection in a tribal population in southern India.

Authors:  Rajiv Sarkar; Anuradha Rose; Venkata R Mohan; Sitara S R Ajjampur; Vasanthakumar Veluswamy; Rajan Srinivasan; Jayaprakash Muliyil; Vedantam Rajshekhar; Kuryan George; Vinohar Balraj; Nicholas C Grassly; Roy M Anderson; Simon J Brooker; Gagandeep Kang
Journal:  Contemp Clin Trials Commun       Date:  2017-03

5.  Effect of Baduanjin exercise intervention on cognitive function and quality of life in women with breast cancer receiving chemotherapy: study protocol of a randomized controlled trial.

Authors:  Xiao-Lin Wei; Ru-Zhen Yuan; Yong-Mei Jin; Shu Li; Ming-Yue Wang; Jie-Ting Jiang; Cai-Qin Wu; Kun-Peng Li
Journal:  Trials       Date:  2021-06-19       Impact factor: 2.279

6.  Combined Transcutaneous Spinal Stimulation and Locomotor Training to Improve Walking Function and Reduce Spasticity in Subacute Spinal Cord Injury: A Randomized Study of Clinical Feasibility and Efficacy.

Authors:  Stephen Estes; Anastasia Zarkou; Jasmine M Hope; Cazmon Suri; Edelle C Field-Fote
Journal:  J Clin Med       Date:  2021-03-11       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.